Article info

Ceramides and phospholipids are downregulated with liraglutide treatment: results from the LiraFlame randomized controlled trial

Authors

  1. Correspondence to Dr Emilie H Zobel; emilie.hein.zobel{at}regionh.dk
View Full Text

Citation

Zobel EH, Wretlind A, Ripa RS, et al
Ceramides and phospholipids are downregulated with liraglutide treatment: results from the LiraFlame randomized controlled trial

Publication history

  • Received May 17, 2021
  • Accepted August 25, 2021
  • First published September 13, 2021.
Online issue publication 
September 13, 2021
  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.